Please enable JavaScript to continue using this application.

Compare $IMVT vs $KOD | Chartloom

Compare

$IMVT vs $KOD

Immunovant Inc · Kodiak Sciences Inc

IMVT

Immunovant Inc

KOD

Kodiak Sciences Inc

Compare $IMVT vs $KOD

Comparing Immunovant Inc and Kodiak Sciences Inc

IMVTImmunovant Inc

KODKodiak Sciences Inc

IMVTImmunovant Inc

Market cap

$6.29B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

17.6%

52W performance

89.5%

FCF yield

-6.6%

KODKodiak Sciences Inc

Market cap

$6.25B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

283.8%

52W performance

590.7%

FCF yield

-2.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMVT

KOD

Detailed metrics comparison

IMVT

Immunovant Inc

KOD

Kodiak Sciences Inc

Market Cap

IMVT$6.29B

KOD$6.25B

Enterprise Value

IMVT$5.49B

KOD$6.12B

Price

IMVT$30.47

KOD$99.87

P/E Ratio

IMVTN/A

KODN/A

P/S Ratio

IMVT0.00x

KOD0.00x

EV/Sales

IMVT0.00x

KOD0.00x

EV/EBITDA

IMVT0.00x

KOD0.00x

P/B Ratio

IMVT9.44x

KOD97.16x

P/FCF Ratio

IMVTN/A

KODN/A

EV/FCF

IMVT-13.25x

KOD-38.30x

PEG Ratio

IMVTN/A

KODN/A

Forward P/E (NTM)

IMVTN/A

KODN/A

Forward P/S (NTM)

IMVTN/A

KODN/A

Revenue (TTM)

IMVT$0

KOD$0

Revenue Growth (YoY)

IMVTN/A

KODN/A

Forward Rev Growth

IMVT546.2%

KOD455.7%

Gross Margin (TTM)

IMVT0.0%

KOD0.0%

Operating Margin (TTM)

IMVT0.0%

KOD0.0%

EBITDA Margin (TTM)

IMVT0.0%

KOD0.0%

Net Margin (TTM)

IMVT0.0%

KOD0.0%

FCF Margin (TTM)

IMVTN/A

KODN/A

Net Income (TTM)

IMVT$-538M

KOD$-242M

FCF (TTM)

IMVT$-414M

KOD$-160M

EPS (TTM)

IMVT-$2.62

KOD-$3.86

ROE (TTM)

IMVT-6959.0%

KOD-27323.0%

ROA (TTM)

IMVT-6250.0%

KOD-8548.0%

ROIC (TTM)

IMVT-6959.0%

KOD-27323.0%

Cash

IMVT$798M

KOD$126M

Debt

IMVT$0

KOD$0

Net Cash/Debt

IMVT$798M

KOD$126M

Current Ratio (TTM)

IMVT7.27x

KOD2.49x

Quick Ratio (TTM)

IMVT6.82x

KOD2.39x

Debt/Equity (TTM)

IMVT0.00x

KOD0.00x

Debt/Assets (TTM)

IMVT0.0%

KOD0.0%

Interest Coverage (TTM)

IMVTN/A

KODN/A

Net Debt/EBITDA (TTM)

IMVT0.00x

KOD0.00x

Beta

IMVT0.92

KOD1.95

52W Performance

IMVT89.5%

KOD590.7%

YTD Performance

IMVT17.6%

KOD283.8%

% from 52W High

IMVT-32.9%

KOD-4.0%

% from 52W Low

IMVT89.5%

KOD812.9%

Asset Turnover (TTM)

IMVT0.00x

KOD0.00x

FCF Yield (TTM)

IMVT-6.6%

KOD-2.6%

Earnings Yield (TTM)

IMVT-8.6%

KOD-3.9%

Dividend Yield (TTM)

IMVTN/A

KODN/A

Rule of 40

IMVT0.0

KOD0.0

EV/GP/RG

IMVTN/A

KODN/A

Ticker research

View IMVT research View KOD research

Metric	IMVT Immunovant Inc	KOD Kodiak Sciences Inc
Market & Valuation
Market Cap	$6.29B	$6.25B
Enterprise Value	$5.49B	$6.12B
Price	$30.47	$99.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	9.44x	97.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.25x	-38.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	546.2%	455.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-538M	$-242M
FCF (TTM)	$-414M	$-160M
EPS (TTM)	-$2.62	-$3.86
ROE (TTM)	-6959.0%	-27323.0%
ROA (TTM)	-6250.0%	-8548.0%
ROIC (TTM)	-6959.0%	-27323.0%
Financial Health
Cash	$798M	$126M
Debt	$0	$0
Net Cash/Debt	$798M	$126M
Current Ratio (TTM)	7.27x	2.49x
Quick Ratio (TTM)	6.82x	2.39x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	1.95
52W Performance	89.5%	590.7%
YTD Performance	17.6%	283.8%
% from 52W High	-32.9%	-4.0%
% from 52W Low	89.5%	812.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-6.6%	-2.6%
Earnings Yield (TTM)	-8.6%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMVT research	View KOD research

Valuation

P/S Ratio

IMVT

0.00x

KOD

0.00x

EV/FCF

KOD

-38.30x

IMVT

-13.25x

Growth & revenue

Forward Revenue Growth

IMVT

546.2%

KOD

455.7%

Profitability & performance

Gross Margin

IMVT

0.0%

KOD

0.0%

ROE

IMVT

-6959.0%

KOD

-27323.0%

FCF Yield %

KOD

-2.6%

IMVT

-6.6%

52-Week Performance

KOD

590.7%

IMVT

89.5%

Detailed metrics comparison

IMVT

Immunovant Inc

KOD

Kodiak Sciences Inc

Market Cap

IMVT$6.29B

KOD$6.25B

Enterprise Value

IMVT$5.49B

KOD$6.12B

Price

IMVT$30.47

KOD$99.87

P/E Ratio

IMVTN/A

KODN/A

P/S Ratio

IMVT0.00x

KOD0.00x

EV/Sales

IMVT0.00x

KOD0.00x

EV/EBITDA

IMVT0.00x

KOD0.00x

P/B Ratio

IMVT9.44x

KOD97.16x

P/FCF Ratio

IMVTN/A

KODN/A

EV/FCF

IMVT-13.25x

KOD-38.30x

PEG Ratio

IMVTN/A

KODN/A

Forward P/E (NTM)

IMVTN/A

KODN/A

Forward P/S (NTM)

IMVTN/A

KODN/A

Revenue (TTM)

IMVT$0

KOD$0

Revenue Growth (YoY)

IMVTN/A

KODN/A

Forward Rev Growth

IMVT546.2%

KOD455.7%

Gross Margin (TTM)

IMVT0.0%

KOD0.0%

Operating Margin (TTM)

IMVT0.0%

KOD0.0%

EBITDA Margin (TTM)

IMVT0.0%

KOD0.0%

Net Margin (TTM)

IMVT0.0%

KOD0.0%

FCF Margin (TTM)

IMVTN/A

KODN/A

Net Income (TTM)

IMVT$-538M

KOD$-242M

FCF (TTM)

IMVT$-414M

KOD$-160M

EPS (TTM)

IMVT-$2.62

KOD-$3.86

ROE (TTM)

IMVT-6959.0%

KOD-27323.0%

ROA (TTM)

IMVT-6250.0%

KOD-8548.0%

ROIC (TTM)

IMVT-6959.0%

KOD-27323.0%

Cash

IMVT$798M

KOD$126M

Debt

IMVT$0

KOD$0

Net Cash/Debt

IMVT$798M

KOD$126M

Current Ratio (TTM)

IMVT7.27x

KOD2.49x

Quick Ratio (TTM)

IMVT6.82x

KOD2.39x

Debt/Equity (TTM)

IMVT0.00x

KOD0.00x

Debt/Assets (TTM)

IMVT0.0%

KOD0.0%

Interest Coverage (TTM)

IMVTN/A

KODN/A

Net Debt/EBITDA (TTM)

IMVT0.00x

KOD0.00x

Beta

IMVT0.92

KOD1.95

52W Performance

IMVT89.5%

KOD590.7%

YTD Performance

IMVT17.6%

KOD283.8%

% from 52W High

IMVT-32.9%

KOD-4.0%

% from 52W Low

IMVT89.5%

KOD812.9%

Asset Turnover (TTM)

IMVT0.00x

KOD0.00x

FCF Yield (TTM)

IMVT-6.6%

KOD-2.6%

Earnings Yield (TTM)

IMVT-8.6%

KOD-3.9%

Dividend Yield (TTM)

IMVTN/A

KODN/A

Rule of 40

IMVT0.0

KOD0.0

EV/GP/RG

IMVTN/A

KODN/A

Ticker research

View IMVT research View KOD research

Metric	IMVT Immunovant Inc	KOD Kodiak Sciences Inc
Market & Valuation
Market Cap	$6.29B	$6.25B
Enterprise Value	$5.49B	$6.12B
Price	$30.47	$99.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	9.44x	97.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.25x	-38.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	546.2%	455.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-538M	$-242M
FCF (TTM)	$-414M	$-160M
EPS (TTM)	-$2.62	-$3.86
ROE (TTM)	-6959.0%	-27323.0%
ROA (TTM)	-6250.0%	-8548.0%
ROIC (TTM)	-6959.0%	-27323.0%
Financial Health
Cash	$798M	$126M
Debt	$0	$0
Net Cash/Debt	$798M	$126M
Current Ratio (TTM)	7.27x	2.49x
Quick Ratio (TTM)	6.82x	2.39x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	1.95
52W Performance	89.5%	590.7%
YTD Performance	17.6%	283.8%
% from 52W High	-32.9%	-4.0%
% from 52W Low	89.5%	812.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-6.6%	-2.6%
Earnings Yield (TTM)	-8.6%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMVT research	View KOD research